行情

ATRS

ATRS

安塔尔制药
NASDAQ

实时行情|Nasdaq Last Sale

2.020
-0.060
-2.88%
盘后: 2.040 +0.02 +0.99% 19:58 04/03 EDT
开盘
2.050
昨收
2.080
最高
2.130
最低
1.930
成交量
106.03万
成交额
--
52周最高
5.13
52周最低
1.600
市值
3.34亿
市盈率(TTM)
-150.7463
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ATRS价格均价为6.50,最高价位9.00,最低价为5.00。

EPS

ATRS 新闻

更多
  • Antares Pharma: An Undervalued Stock To Buy During The COVID-19 Crisis
  • Seeking Alpha - Article · 2天前
  • Edited Transcript of ATRS earnings conference call or presentation 3-Mar-20 1:30pm GMT
  • Thomson Reuters StreetEvents · 03/22 05:20
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • Raymond James Maintains Strong Buy on Antares Pharma, Raises Price Target to $6
  • Benzinga · 03/04 12:22

所属板块

医疗设备、用品及经销
-0.92%
医疗设备和用品
-1.17%

热门股票

代码
价格
涨跌幅

ATRS 简况

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.
展开

微牛提供Antares Pharma Inc(NASDAQ-ATRS)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ATRS股票新闻,以帮助您做出投资决策。